IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in[...]
American Strategic Investment Co.
Expects to Accelerate Efforts to Diversify Through the Divestiture of[...]
Quarterly Report for Quarter Ending March 31, 2024 (Form 10-Q)
03/27/2024 | Press release | Distributed by Public on 03/27/2024 13:55
Please select the service you want to use:
Smartlinks | Maple Leaf Foods Inc. | News | Human Rights | Social and Non-Profit | Human Rights | Human Rights | Company News | Top Company News | Securities Issuers | Meat Processing and Preserving Companies | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Toronto Stock Exchange (TSX) | Stuttgart Stock Exchange | OTC Markets | Cboe Canada | Omega ATS | Lynx ATS | CSE Pure Trading | Nasdaq CX2 | Nasdaq CXC | TSX Alpha Exchange
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact